NeuroFlow is a digital health company combining workflow automation, patient engagement solutions and services, and applied AI to promote behavioral health integration in all care settings. The company leverages advanced NLP technology to identify behavioral health risks, including suicidal ideation, that traditional screening methods may miss, positioning itself as a critical infrastructure provider for healthcare systems navigating the mental-physical health integration challenge.
Cyborg Score Rationale
NeuroFlow has raised $72.3M, demonstrating strong investor backing. The company has 200 employees, indicating scale and operational maturity. The company operates in the high-growth behavioral health technology space with proven clinical value and strategic partnerships.
Top Insights
Advanced NLP technology identifies 58% more suicidal risk cases than traditional screening alone, creating significant clinical safety differentiator
Serves all three healthcare constituencies—payors, health systems, and federal government—providing diversified revenue stability
Behavioral health integration is a healthcare macro trend driven by parity requirements and rising mental health burden, positioning NeuroFlow in structurally growing market
Named Competitors
Mindoula — Behavioral health engagement and care coordination
Headspace — Digital mental health and meditation platform
Lyra Health — Behavioral health integration and care management
HealthRhythms — Remote patient monitoring for behavioral health
Recent Developments
(April 2026) Updated product capabilities and platform features for behavioral health risk identification
(February 2026) Expanded partnerships with health systems for behavioral health identification and care coordination
(June 2025) Released update to BHIQ analytics suite with enhanced cost management capabilities
Open the full interactive NeuroFlow, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.